| Not a member? Join now!
Innovations in chemistry often lead to breakthroughs in biology and medicine. This symposium highlights advances in bioorthogonal chemistry, affording opportunities to explore biology and facilitating the synthesis of diagnostics and therapeutics.
Antibody-drug conjugates (ADCs) promise safer, more effective therapies than standard anti-cancer drugs. This symposium highlights linker-payload and coupling chemistries, ADC development, biomarker and patient selection, and regulatory perspectives.
The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. The year-end meeting features keynote speaker Michael Marletta of the Scripps Research Institute and a poster session.
Blavatnik Award winning scientist Dr. Jonathan Fisher discusses the power of various visualization techniques in researching—and educating about—the brain.